VERACYTE, INC. Security Deposit
VERACYTE, INC. (VCYT) had Security Deposit of $1.70 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › and Other Assets
us-gaap:SecurityDeposit · last filed 2026-07-31
- 2026-06-30: Security Deposit $1.70M.
- 2026-03-31: Security Deposit $1.70M.
- 2025-12-31: Security Deposit $1.60M.
- 2025-09-30: Security Deposit $1.60M.
| Period end | Security Deposit |
|---|---|
| 2026-06-30 | $1.70M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $1.70M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.60M 10-Q · filed 2026-07-31 |
| 2025-09-30 | $1.60M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.70M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.60M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.10M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.10M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.10M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $900.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $900.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $900.00K 10-Q · filed 2023-08-09 |
| 2022-12-31 | $700.00K 10-K · filed 2024-02-29 |
| 2014-09-30 | $75.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $75.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $75.00K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $75.00K 10-Q · filed 2014-11-13 |
| 2012-12-31 | $75.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |